David E. Kemp

3.9k total citations
71 papers, 2.6k citations indexed

About

David E. Kemp is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, David E. Kemp has authored 71 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Psychiatry and Mental health, 16 papers in Clinical Psychology and 12 papers in Pharmacology. Recurrent topics in David E. Kemp's work include Bipolar Disorder and Treatment (50 papers), Schizophrenia research and treatment (27 papers) and Electroconvulsive Therapy Studies (18 papers). David E. Kemp is often cited by papers focused on Bipolar Disorder and Treatment (50 papers), Schizophrenia research and treatment (27 papers) and Electroconvulsive Therapy Studies (18 papers). David E. Kemp collaborates with scholars based in United States, China and Canada. David E. Kemp's co-authors include Joseph R. Calabrese, Keming Gao, Stephen J. Ganocy, Roger S. McIntyre, Joanna K. Soczynska, Benjamin I. Goldstein, Robert L. Findling, Carla Conroy, Philip K. Chan and David J. Muzina and has published in prestigious journals such as American Journal of Psychiatry, Journal of Abnormal Psychology and Journal of Affective Disorders.

In The Last Decade

David E. Kemp

66 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David E. Kemp United States	28	1.8k	569	452	357	226	71	2.6k
Jakub Z. Konarski Canada	28	1.5k 0.8×	402 0.7×	510 1.1×	424 1.2×	309 1.4×	47	2.8k
K. N. Roy Chengappa United States	33	2.4k 1.3×	530 0.9×	577 1.3×	379 1.1×	107 0.5×	98	3.7k
David J. Bond Canada	32	2.4k 1.3×	897 1.6×	380 0.8×	562 1.6×	93 0.4×	76	3.4k
Mohammad Alsuwaidan Canada	22	881 0.5×	444 0.8×	355 0.8×	552 1.5×	229 1.0×	37	2.2k
Hanna O. Woldeyohannes Canada	30	1.5k 0.8×	841 1.5×	460 1.0×	754 2.1×	412 1.8×	50	3.3k
Jaspreet S. Brar United States	28	1.6k 0.8×	471 0.8×	341 0.8×	198 0.6×	225 1.0×	76	2.8k
Iría Grande Spain	28	3.0k 1.6×	1.0k 1.8×	686 1.5×	447 1.3×	80 0.4×	92	4.2k
Astrid B. Birkenaes Norway	20	1.4k 0.8×	252 0.4×	318 0.7×	101 0.3×	140 0.6×	23	1.9k
Ariel Gildengers United States	28	1.7k 0.9×	287 0.5×	432 1.0×	423 1.2×	43 0.2×	74	2.6k
Fabiano A. Gomes Canada	16	1.0k 0.6×	573 1.0×	243 0.5×	121 0.3×	63 0.3×	38	1.6k

Countries citing papers authored by David E. Kemp

Since Specialization

Citations

This map shows the geographic impact of David E. Kemp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Kemp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Kemp more than expected).

Fields of papers citing papers by David E. Kemp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Kemp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Kemp. The network helps show where David E. Kemp may publish in the future.

Co-authorship network of co-authors of David E. Kemp

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Kemp. A scholar is included among the top collaborators of David E. Kemp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Kemp. David E. Kemp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Ranran, Renrong Wu, Jun Chen, et al.. (2025). A Randomized, Placebo-Controlled Pilot Study of Quetiapine-XR Monotherapy or Adjunctive Therapy to Antidepressant in Acute Major Depressive Disorder with Current Generalized Anxiety Disorder. Psychopharmacology Bulletin. 46(1). 8–23.

Khatib, Rasha, et al.. (2023). Design and Implementation of a Digitally Enabled Care Pathway to Improve Management of Depression in a Large Health Care System: Protocol for the Implementation of a Patient Care Platform. JMIR Research Protocols. 12. e43788–e43788. 2 indexed citations

McCue, Maggie, James R. King, Francesca Cormack, et al.. (2022). Mobile App to Enhance Patient Activation and Patient-Provider Communication in Major Depressive Disorder Management: Collaborative, Randomized Controlled Pilot Study. JMIR Formative Research. 6(10). e34923–e34923. 10 indexed citations

Aftab, Awais, David E. Kemp, Stephen J. Ganocy, et al.. (2018). Double-blind, placebo-controlled trial of pioglitazone for bipolar depression. Journal of Affective Disorders. 245. 957–964. 31 indexed citations

Gao, Keming, Renrong Wu, Zuowei Wang, et al.. (2014). Disagreement between self-reported and clinician-ascertained suicidal ideation and its correlation with depression and anxiety severity in patients with major depressive disorder or bipolar disorder. Journal of Psychiatric Research. 60. 117–124. 33 indexed citations

Kemp, David E., Christoph U. Correll, Mauricio Tohen, et al.. (2013). Associations Among Obesity, Acute Weight Gain, and Response to Treatment with Olanzapine in Adolescent Schizophrenia. Journal of Child and Adolescent Psychopharmacology. 23(8). 522–530. 36 indexed citations

Kemp, David E., Jun Zhao, Pilar Cazorla, et al.. (2013). Weight Change and Metabolic Effects of Asenapine in Patients With Schizophrenia and Bipolar Disorder. The Journal of Clinical Psychiatry. 75(3). 238–245. 23 indexed citations

Gao, Keming, Zuowei Wang, Jun Chen, et al.. (2012). Should an assessment of Axis I comorbidity be included in the initial diagnostic assessment of mood disorders? Role of QIDS-16-SR total score in predicting number of Axis I comorbidity. Journal of Affective Disorders. 148(2-3). 256–264. 36 indexed citations

Kemp, David E., Keming Gao, Philip K. Chan, et al.. (2012). Lamotrigine as add‐on treatment to lithium and divalproex: lessons learned from a double‐blind, placebo‐controlled trial in rapid‐cycling bipolar disorder. Bipolar Disorders. 14(7). 780–789. 26 indexed citations

10.

Kemp, David E., Faramarz Ismail‐Beigi, Stephen J. Ganocy, et al.. (2011). Use of insulin sensitizers for the treatment of major depressive disorder: A pilot study of pioglitazone for major depression accompanied by abdominal obesity. Journal of Affective Disorders. 136(3). 1164–1173. 88 indexed citations

11.

Wang, Zuowei, David E. Kemp, Philip K. Chan, et al.. (2010). Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study.. PubMed. 43(4). 5–21. 26 indexed citations

12.

Gao, Keming, David E. Kemp, Zuowei Wang, et al.. (2010). Number Needed to Treat to Harm for Discontinuation Due to Adverse Events in the Treatment of Bipolar Depression, Major Depressive Disorder, and Generalized Anxiety Disorder With Atypical Antipsychotics. The Journal of Clinical Psychiatry. 72(8). 1063–1071. 51 indexed citations

13.

Gao, Keming, Philip K. Chan, Marcia L. Verduin, et al.. (2010). Independent Predictors for Lifetime and Recent Substance Use Disorders in Patients with Rapid‐Cycling Bipolar Disorder: Focus on Anxiety Disorders. American Journal on Addictions. 19(5). 440–449. 25 indexed citations

14.

McIntyre, Roger S., Natalie Rasgon, David E. Kemp, et al.. (2009). Metabolic syndrome and major depressive disorder: Co-occurrence and pathophysiologic overlap. Current Diabetes Reports. 9(1). 51–59. 108 indexed citations

15.

McIntyre, Roger S., David J. Muzina, David E. Kemp, et al.. (2008). Bipolar disorder and suicide: Research synthesis and clinical translation. Current Psychiatry Reports. 10(1). 66–72. 63 indexed citations

16.

Kemp, David E., Keming Gao, Stephen J. Ganocy, et al.. (2008). A 6-Month, Double-Blind, Maintenance Trial of Lithium Monotherapy Versus the Combination of Lithium and Divalproex for Rapid-Cycling Bipolar Disorder and Co-Occurring Substance Abuse or Dependence. The Journal of Clinical Psychiatry. 70(1). 113–121. 66 indexed citations

17.

Gao, Keming, Marcia L. Verduin, David E. Kemp, et al.. (2008). Clinical Correlates of Patients With Rapid-Cycling Bipolar Disorder and a Recent History of Substance Use Disorder. The Journal of Clinical Psychiatry. 69(7). 1057–1063. 16 indexed citations

18.

Muzina, David J., David E. Kemp, & Roger S. McIntyre. (2007). Differentiating Bipolar Disorders from Major Depressive Disorders: Treatment Implications. Annals of Clinical Psychiatry. 19(4). 305–312. 28 indexed citations

19.

Calabrese, Joseph R., David J. Muzina, David E. Kemp, et al.. (2006). Predictors of bipolar disorder risk among patients currently treated for major depression.. PubMed. 8(3). 38–38. 37 indexed citations

20.

Kemp, David E. & Kathleen N. Franco. (2002). Possible leukopenia associated with long-term use of echinacea.. PubMed. 15(5). 417–9. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact